← Open Payments lookup

JAY LENTZNER: Open Payments

NPI 1982884904 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,026 in 39 payments from 10 companies in 2025. Trend: 2023 $4,752 · 2024 $4,780 · 2025 $1,026

Food & beverage: $1,026
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$301
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$140
Otsuka America Pharmaceutical, Inc.5$124
ABBVIE INC.5$109
Vanda Pharmaceuticals Inc.5$105
Lundbeck LLC3$74
Neurocrine BioSciences, Inc.2$62
Alkermes, Inc.2$49
Teva Pharmaceuticals USA, Inc.1$32
Axsome Therapeutics, Inc.1$29

Products named: REXULTI, INVEGA SUSTENNA, CAPLYTA, SPRAVATO, VRAYLAR, FANAPT, INGREZZA, ARISTADA.

Industry payments across CA — which companies pay providers there.